Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
|
Product:
Active Ingredients:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
|
Moxifloxacin Kabi
Moxifloxacin hydrochloride 1.75mg/mL
equivalent to moxifloxacin 1.6mg/mL
Solution for infusion
Fresenius Kabi New Zealand Limited
Fresenius Kabi Norge AS, Halden, Norway
Fresenius Kabi Polska Sp. z o.o., Kutno, Poland
|
|
Product:
Active Ingredients:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Naloxone Multichem
Naloxone hydrochloride dihydrate 0.44mg/mL
equivalent to naloxone hydrochloride 0.4mg/mL
Solution for injection
Multichem NZ Limited
Medochemie Limited, Limassol, Cyprus
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Riximyo
Rituximab 10mg/mL
Concentrate for infusion
Novartis New Zealand Limited
Lek Pharmaceuticals d.d., Ljubljana, Slovenia
|
Dated this 29th day of October 2018.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Gazette.govt.nz